Radioguidance that makes use of β-emitting radionuclides is gaining in popularity and could have potential to strengthen the range of existing radioguidance techniques. While there is a …
G Feliciani, M Celli, F Ferroni, E Menghi, I Azzali… - Cancers, 2022 - mdpi.com
Simple Summary Radiomics analysis is used on magnetic resonance imaging–apparent diffusion coefficient (MRI-ADC) maps and [68Ga] Ga-PSMA-11 PET uptake maps to assess …
E Koseoglu, Y Kordan, M Kilic, O Sal… - Prostate Cancer and …, 2021 - nature.com
Background To evaluate the additive role of Ga-68 PSMA PET as a primary staging tool in patients bearing prostate cancer in single PIRADS 4 or 5 index lesions. Methods Eighty-one …
CD Bahler, MA Green, MA Tann, JK Swensson… - … oncology: seminars and …, 2023 - Elsevier
Background Incontinence and impotence occur following radical prostatectomy due to injury to nerves and sphincter muscle. Preserving nerves and muscle adjacent to prostate cancer …
A Cimadamore, L Cheng, A Lopez-Beltran… - European Urology …, 2021 - Elsevier
Context Whole-mount histopathology, that is, large format histology or whole-mount sectioning, refers to the histopathological examination of tissue sections from specimens …
S Dekalo, J Kuten, I Mintz, I Fahoum… - Prostate Cancer and …, 2021 - nature.com
Background High-risk prostate cancer is associated with adverse pathology and unfavorable outcomes after radical prostatectomy. 68Ga-PSMA PET/CT is more accurate than …
Abstract Context Prostate cancer (PCa) remains one of the leading causes of cancer-related deaths in men worldwide. Men at risk are typically offered multiparametric magnetic …
X Du, Y Dong, J Liu, Y Su, Y Zhu, J Pan, B Dong… - The …, 2023 - Wiley Online Library
Background The precise staging and proper management of high‐risk prostate cancer (PCa) continues to be a challenge. We aimed to demonstrate the prognostic value of …
L Duan, Z Liu, F Wan, B Dai - BMC cancer, 2024 - Springer
Whole-mount histopathology (WMH) has been a powerful tool to investigate the characteristics of prostate cancer. However, the latest advancement of WMH was yet under …